Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- April 2008
- DOI:
- 10.1371/journal.pone.0001927
- Bibcode:
- 2008PLoSO...3.1927V